Page last updated: 2024-08-26

osajin and Prostatic Neoplasms, Castration-Resistant

osajin has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hsieh, PF; Huang, GJ; Huang, SY; Huang, WC; Wu, HC	1

Other Studies

1 other study(ies) available for osajin and Prostatic Neoplasms, Castration-Resistant

Article	Year
Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression. The Prostate, 2019, Volume: 79, Issue:13 Topics: Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Down-Regulation; Fatty Acid Synthase, Type I; Humans; Isoflavones; Kallikreins; Lipogenesis; Male; Neoplasm Invasiveness; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen	2019

Article

Year

Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression.

The Prostate, 2019, Volume: 79, Issue:13

Topics: Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Down-Regulation; Fatty Acid Synthase, Type I; Humans; Isoflavones; Kallikreins; Lipogenesis; Male; Neoplasm Invasiveness; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2019